232 related articles for article (PubMed ID: 18627649)
1. What is the evidence for the use of probiotics in functional disorders?
Quigley EM
Curr Gastroenterol Rep; 2008 Aug; 10(4):379-84. PubMed ID: 18627649
[TBL] [Abstract][Full Text] [Related]
2. Probiotics in functional gastrointestinal disorders: what are the facts?
Quigley EM
Curr Opin Pharmacol; 2008 Dec; 8(6):704-8. PubMed ID: 18775516
[TBL] [Abstract][Full Text] [Related]
3. Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date.
Quigley EM; Flourie B
Neurogastroenterol Motil; 2007 Mar; 19(3):166-72. PubMed ID: 17300285
[TBL] [Abstract][Full Text] [Related]
4. Emerging role of probiotics and antimicrobials in the management of irritable bowel syndrome.
Cash BD
Curr Med Res Opin; 2014 Jul; 30(7):1405-15. PubMed ID: 24666019
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
Bai T; Zeng H; Long Y; Li X; Sun X; Lan Y; Gao L; Zhang L; Feng Z; Hou X
Trials; 2020 Jun; 21(1):597. PubMed ID: 32605578
[TBL] [Abstract][Full Text] [Related]
6. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of probiotics in IBS.
Quigley EM
J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S85-90. PubMed ID: 18542036
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
Didari T; Mozaffari S; Nikfar S; Abdollahi M
World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308
[TBL] [Abstract][Full Text] [Related]
9. Probiotics in the management of functional bowel disorders: promise fulfilled?
Quigley EM
Gastroenterol Clin North Am; 2012 Dec; 41(4):805-19. PubMed ID: 23101688
[TBL] [Abstract][Full Text] [Related]
10. The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Sun YY; Li M; Li YY; Li LX; Zhai WZ; Wang P; Yang XX; Gu X; Song LJ; Li Z; Zuo XL; Li YQ
Sci Rep; 2018 Feb; 8(1):2964. PubMed ID: 29445178
[TBL] [Abstract][Full Text] [Related]
11. Probiotics in Irritable Bowel Syndrome: The Science and the Evidence.
Quigley EM
J Clin Gastroenterol; 2015; 49 Suppl 1():S60-4. PubMed ID: 26447967
[TBL] [Abstract][Full Text] [Related]
12. Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last?
Bixquert Jiménez M
Rev Esp Enferm Dig; 2009 Aug; 101(8):553-64. PubMed ID: 19785495
[TBL] [Abstract][Full Text] [Related]
13. Probiotics in irritable bowel syndrome: an immunomodulatory strategy?
Quigley EM
J Am Coll Nutr; 2007 Dec; 26(6):684S-90S. PubMed ID: 18187434
[TBL] [Abstract][Full Text] [Related]
14. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.
Ishaque SM; Khosruzzaman SM; Ahmed DS; Sah MP
BMC Gastroenterol; 2018 May; 18(1):71. PubMed ID: 29801486
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis.
Ford AC; Quigley EM; Lacy BE; Lembo AJ; Saito YA; Schiller LR; Soffer EE; Spiegel BM; Moayyedi P
Am J Gastroenterol; 2014 Oct; 109(10):1547-61; quiz 1546, 1562. PubMed ID: 25070051
[TBL] [Abstract][Full Text] [Related]
16. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy.
Camilleri M
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S123-5. PubMed ID: 18806702
[TBL] [Abstract][Full Text] [Related]
17. Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice -- an evidence-based international guide.
Hungin AP; Mulligan C; Pot B; Whorwell P; Agréus L; Fracasso P; Lionis C; Mendive J; Philippart de Foy JM; Rubin G; Winchester C; de Wit N;
Aliment Pharmacol Ther; 2013 Oct; 38(8):864-86. PubMed ID: 23981066
[TBL] [Abstract][Full Text] [Related]
18. Probiotics and functional gastrointestinal disorders in children.
Vandenplas Y; Benninga M
J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S107-9. PubMed ID: 19300120
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
Harris LA; Baffy N
Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of probiotics for the treatment of irritable bowel syndrome.
McFarland LV; Dublin S
World J Gastroenterol; 2008 May; 14(17):2650-61. PubMed ID: 18461650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]